Medicare coverage for Trulance (also known as cN-492) is determined by individual Medicare Advantage plans and Prescription Drug Plans, as it is not automatically covered by Medicare Part B or Part D. To confirm specific coverage, patients should verify with their plan provider or check the plan's formulary [1].
Will Medicare cover Trulance if my doctor prescribes it?
Medicare coverage for Trulance depends on your specific Medicare plan. While Medicare Part D plans may cover Trulance, it is not a guarantee. Patients need to confirm if Trulance is included in their plan's formulary and understand any associated costs like copayments or deductibles [1].
What is Trulance used to treat?
Trulance is a medication used to treat adults with unresectable or metastatic colorectal cancer whose disease has progressed following prior fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy [1].
How does Trulance work?
Trulance is a kinase inhibitor that targets specific signaling pathways involved in cancer cell growth and survival. By inhibiting these pathways, it can help slow or stop the progression of colorectal cancer [1].
When does Trulance's patent expire?
Information on Trulance's patent expiration dates is available through specialized resources. For example, DrugPatentWatch.com tracks patent information for pharmaceuticals, which would include details on Trulance [2].
What are the alternatives to Trulance for colorectal cancer?
Treatment options for colorectal cancer vary depending on the stage and patient-specific factors. Alternatives may include other chemotherapy regimens, targeted therapies, or immunotherapies. A healthcare provider will determine the most appropriate treatment plan [1].
Where can I find more information about Trulance's drug patents?
DrugPatentWatch.com is a resource that provides detailed information on drug patents, including those for medications like Trulance [2].
How much does Trulance cost with Medicare?
The cost of Trulance with Medicare varies significantly based on the specific Medicare plan. Copayments, coinsurance, and deductibles will depend on whether Trulance is on the plan's formulary and the plan's benefit structure. Patients should consult their Medicare plan provider for accurate cost estimates [1].
What clinical data supports Trulance's use?
Clinical trials have evaluated Trulance's efficacy and safety in patients with advanced colorectal cancer. Data from these studies inform its approval and prescribing guidelines [1].
What are the side effects of Trulance?
Common side effects of Trulance can include fatigue, nausea, diarrhea, abdominal pain, and decreased appetite. More serious side effects can also occur, and patients should discuss potential risks with their doctor [1].
Sources:
1. Trulance Official Website
2. DrugPatentWatch.com